Arkolith/Insider Trading/CNSP/Form 4

Evans Carl Anthony

DirectorCNS Pharmaceuticals, Inc. (CNSP) · full profile →Form 4 · filed Feb 6, 2024
Net Buying
Open-Market Buys
$10K
Open-Market Sells
$0
Net Open-Market Flow
$10K
Transactions
3
1 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 1, 2024Buy(P)33K$0.30$10K33K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 1, 2024Grant(A)33K——112K
Feb 1, 2024Grant(A)33K——79K

Transaction Codes

P
Open-market purchase
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001683168-24-000707) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for CNS Pharmaceuticals, Inc.

Build

Ask your agent about CNSP insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001683168-24-000707"
Ask your agent
Use Arkolith to summarize insider buying and selling at CNS Pharmaceuticals, Inc.
over the last 90 days and cite the filings.